Is there an association between liraglutide use and female breast cancer in a real-world setting?

Is there an association between liraglutide use and female breast cancer in a real-world setting?

Donnie Funch,1 Kathleen Mortimer,1 Ling Li,1 Heather Norman,1 Atheline Major-Pedersen,2 Anne Helene Olsen,3 Margit S Kaltoft,4 David D Dore1,5 1Optum Epidemiology, Boston, MA, USA; 2Global Safety, Novo Nordisk A/S, Copenhagen, Denmark; 3Epidemiology, Novo Nordisk A/S, Copenhagen, Denmark; 4Global De...

Full description

Saved in:
Bibliographic Details
Main Authors: Funch D, Mortimer K, Li L, Norman H, Major-Pedersen A, Olsen AH, Kaltoft MS, Dore DD
Format: article
Language:EN
Published: Dove Medical Press 2018
Subjects:
Glucagon-like peptide-1 receptor agonist
type 2 diabetes
administrative claims
intention-to-treat
time-on-drug
Specialties of internal medicine
RC581-951
Online Access:https://doaj.org/article/e936f0198d98452b809e9267a0daf4a8
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items